Granules India profit surges as higher sales outweigh cost pressures 

Nov 2 (Reuters) – Indian drugmaker Granules India reported a second-quarter profit rise of nearly 40% on Monday, as new product launches and strong sales of its main medicines in key overseas markets

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)